US-based scientific instruments manufacturer Bruker has introduced four new preclinical imaging systems at the World Molecular Imaging Congress (WMIC) 2015 in Honolulu, Hawaii, US.
The products deliver improved performance and convenience for routine imaging and provides opportunities for advanced translational research, while the company’s platform philosophy facilitates multimodal imaging projects.
The recently launched Albira Si PET/SPECT/CT system will provide sub-millimetre spatial resolution across the full radial field of view (FOV), enhancing high-resolution FOV by an order of magnitude compared against traditional PET systems.
Albira Si also provides the benefits of integration with SPECT and CT, while micro-CT provides anatomical reference images and attenuation corrections for PET and SPECT imaging.
The system is also compatible with the firm’s multimodal animal beds for cross-platform MRI and optical molecular imaging.
Bruker Preclinical Imaging Division president Dr Wulf Jung said: "At WMIC 2015, Bruker is demonstrating clear performance leadership in preclinical PET/CT and PET/MRI, and we are pleased to respond to our customers’ demand for a translational research 3 Tesla preclinical MRI with robust cryogen-free magnet technology."
The company’s BioSpec 3T Preclinical MRI system features cryogen-free magnet technology, which overcomes the reliability limitations of older cryogen-free magnets.
Featuring an 18cm magnet bore, the BioSpec 3T system can be upgraded to PET/MRI.
Bruker’s MRI CyroProbe for mice and rats, MRI sensitivity and spatial resolution can optionally be increased compared to conventional 7T MRI.
ParaVision 6 software features validated in-vivo protocols and a preclinical user interface, which unites workflows across different modalities with facile multi-modality image fusion.
The new BioSpec 3T PET/MRI is a combination of Albira Si PET detector technology and MRI soft tissue contrast in one compact instrument.
Built-in multimodal animal beds are said to be fully compatible with other Bruker molecular imaging systems.
High-sensitivity Xtreme II optical molecular imaging system is comprised of a new CCD camera that provides new levels of performance during low-light applications such as bioluminescence and Cerenkov imaging.
With five imaging modalities, the Xtreme II system allows for co-registration of molecular events with access to bioluminescence, multispectral VIS-NIR fluorescence, unique direct radioisotopic imaging, and Cerenkov radiation.
Image: BioSpec 3T Preclinical MRI System with superior cryogen-free magnet. Photo: courtesy of Bruker Corporation.